Circulating Cell-Free DNA as a Prognostic Biomarker in Resectable Ampullary Cancer
Sign Up to like & getrecommendations! Published in 2021 at "Cancers"
DOI: 10.3390/cancers13102313
Abstract: Simple Summary Circulating cell-free DNA (cfDNA) in patients with ampullary cancer was measured to clarify the correlation between cfDNA and clinicopathological factors and the impact of cfDNA on survival outcomes. The level of cfDNA was… read more here.
Keywords: ampullary cancer; level; 6687 copies; cfdna ... See more keywords